TY - JOUR AU - Longo, Miriam AU - Caruso, Paola AU - Maiorino, Maria Ida AU - Bellastella, Giuseppe AU - Giugliano, Dario AU - Esposito, Katherine PY - 2020 DA - 2020/07/22 TI - Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies JO - Cardiovascular Diabetology SP - 115 VL - 19 IS - 1 AB - The coronavirus disease 2019 (COVID-19) has been declared as pandemic by the World Health Organization and is causing substantial morbidity and mortality all over the world. Type 2 diabetes, hypertension, and cardiovascular disease significantly increase the risk for hospitalization and death in COVID-19 patients. Hypoglycemia and hyperglycemia are both predictors for adverse outcomes in hospitalized patients. An optimized glycemic control should be pursued in patients with diabetes and SARS-CoV-2 infection in order to reduce the risk of severe COVID-19 course. Both insulin and GLP-1RAs have shown optimal glucose-lowering and anti-inflammatory effects in type 2 diabetic patients and may represent a valid therapeutic option to treat asymptomatic and non-critically ill COVID-19 diabetic patients. SN - 1475-2840 UR - https://doi.org/10.1186/s12933-020-01090-9 DO - 10.1186/s12933-020-01090-9 ID - Longo2020 ER -